Start for free
Start for free
Green Cross Holding logo

Green Cross Holding

Asia, Kyongsang-bukto, South Korea, Gyeongju

Description

GC holding company, which operates pharmaceutical, biotechnology, distribution system, life insurance, and healthcare entities.

Investor Profile

Green Cross Holding has made 7 investments, with 1 in the past 12 months and 14% as lead.

Stage Focus

  • Series A (57%)
  • Series B (43%)

Country Focus

  • United States (71%)
  • Canada (14%)
  • South Korea (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Life Science
  • Communities
  • Mobile Apps
  • Online Portals
  • Q&a
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Green Cross Holding frequently co-invest with?

venBio Partners
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 2
E&Investment
E&Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Asahi Kasei Corporate Venture Capital
Asahi Kasei Corporate Venture Capital
North America, California, United States, Menlo Park
Co-Investments: 1
5AM Ventures
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
AQC Capital
AQC Capital
North America, Quebec, Canada, Montréal
Co-Investments: 1
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Green Cross Lab Cell
Green Cross Lab Cell
Asia, Ch'ungch'ong-namdo, South Korea, Yongin
Co-Investments: 2
Adjuvant Capital
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 3
Anges Quebec
Anges Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 1
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4

What are some of recent deals done by Green Cross Holding?

Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

BiopharmaBiotechnologyHealth CareMedical
Series BMar 17, 2025
Amount Raised: $110,000,000
Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotech firm that focuses on producing vaccines.

BiopharmaBiotechnologyHealth Care
Series ANov 16, 2022
Amount Raised: $26,000,000
MiNDCAFE

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

MiNDCAFE is an online psychological counseling and mind-healing platform.

CommunitiesHealth CareMobile AppsOnline PortalsQ&A
Series BFeb 10, 2022
Amount Raised: $17,000,000
Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotech firm that focuses on producing vaccines.

BiopharmaBiotechnologyHealth Care
Series AJan 7, 2022
Amount Raised: $60,000,000
Artiva Biotherapeutics

San Diego, California, United States

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

BiotechnologyLife ScienceTherapeutics
Series BFeb 26, 2021
Amount Raised: $120,000,000
Artiva Biotherapeutics

San Diego, California, United States

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

BiotechnologyLife ScienceTherapeutics
Series AJun 26, 2020
Amount Raised: $78,000,000
Feldan Therapeutics

Quebec, Quebec, Canada

Feldan Therapeutics has developed a patented peptide-based technology platform.

BiotechnologyTherapeutics
Series ASep 18, 2018
Amount Raised: $13,800,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator